Skip to content

Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD

Prevalence of Lidocaine Ineffectiveness in Those With Hard-to-treat ADHD

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04167189
Enrollment
28
Registered
2019-11-18
Start date
2018-01-20
Completion date
2020-03-30
Last updated
2021-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Brief summary

This work will assess the prevalence in hard-to-treat ADHD of the ineffectiveness of the anesthetic Lidocaine.

Detailed description

Using a non-invasive, pain-free, taste-based approach to assess lidocaine effectiveness, the study will assess the frequency of ineffectiveness in the target population.

Interventions

Septodont 5% oral lidocaine gel (NDC 0362-0221-10), 75 mg

Sponsors

NeurAbilities (formerly CRCNJ)
CollaboratorOTHER
PhenoSolve, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

The scoring of the lidocaine test is masked, using the coded identity of the tastes. The tastes will be assessed in random order. The subjects and other study personnel will be told not to discuss what the subject could or couldn't taste. Scoring will not be shared with the testing site until all testing is complete. This is one of the last studies with an IRB for each arm and site. Hence it appears to be a single arm, but the other arms are separately registered with ClinicalTrials.gov

Intervention model description

Using a taste-based test before and after the application of lidocaine gel to the tongue, we will assess the degree to which lidocaine is effective at blocking taste in those with hard-to-treat ADHD

Eligibility

Sex/Gender
ALL
Age
7 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

ADHD

Exclusion criteria

for both arms: 1. known adverse reactions to lidocaine 2. epilepsy, IQ \<80, severe head trauma, birth weight \<2270 grams, and severe autism; 3. treatment currently with potassium or potassium-elevating drugs such as renin-angiotensin-aldosterone blockers; 4. generalized anxiety disorders (but dental-specific anxiety will not be an exclusion because many of these individuals may be ones with anxiety because of painful dental experiences with lidocaine ineffectiveness); 5. mouth sores; 6. Ehlers Danlos syndrome, and 7. red hair.

Design outcomes

Primary

MeasureTime frameDescription
Observational Study: Number of Participants With Lidocaine Ineffectiveness by Taste Test in Hard-to-treat ADHDon day of testing, approximately 30 minutes for clinic visitSubjects will be asked to identify each taste and its intensity.

Countries

United States

Participant flow

Participants by arm

ArmCount
Hard-to-treat ADHD
Subjects will be tested with Septodont 5% oral lidocaine gel (NDC 0362-0221-10), 75 mg pre-measured by compounding pharmacy and dispensed into blister pack
28
Total28

Baseline characteristics

CharacteristicHard-to-treat ADHD
Age, Continuous16 years
STANDARD_DEVIATION 7
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Hard-to-treat ADHD (does not respond to available ADHD drugs)28 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
22 Participants
Region of Enrollment
United States
28 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Observational Study: Number of Participants With Lidocaine Ineffectiveness by Taste Test in Hard-to-treat ADHD

Subjects will be asked to identify each taste and its intensity.

Time frame: on day of testing, approximately 30 minutes for clinic visit

Population: Study population vs. previously published studies in pediatric populations (Nakai et al, 2000)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Hard-to-treat ADHDObservational Study: Number of Participants With Lidocaine Ineffectiveness by Taste Test in Hard-to-treat ADHDLidocaine effective (got numb)1 Participants
Hard-to-treat ADHDObservational Study: Number of Participants With Lidocaine Ineffectiveness by Taste Test in Hard-to-treat ADHDLidocaine ineffective (did not get numb)27 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026